NCT03683589View on ClinicalTrials.gov

De Novo Lipogenesis in Severity of NAFLD

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

August 21, 2019

Study Completion Date

July 31, 2020

Conditions
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisBariatric Surgery CandidateObesity, Morbid
Trial Locations (1)

65212

University of Missouri, Columbia

All Listed Sponsors
collaborator

American Society for Nutrition

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Missouri-Columbia

OTHER

NCT03683589 - De Novo Lipogenesis in Severity of NAFLD | Biotech Hunter | Biotech Hunter